EFNB1 and esophageal squamous cell carcinoma: Functional experiments have demonstrated that aberrant EFNB1-EPHB4 interaction in epithelial cells accelerates ESCC progression via enhanced cell cycle and epithelial-mesenchymal transition (EMT) pathways both activated by SRC/ERK/AKT signaling.